Q3 2016 13F Holders as of 30 Sep 2016
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
54,486,781
-
Number of holders
-
197
-
Total 13F shares, excl. options
-
35,869,477
-
Shares change
-
-163,763
-
Total reported value, excl. options
-
$1,129,692,915
-
Value change
-
-$1,397,280
-
Put/Call ratio
-
27%
-
Number of buys
-
116
-
Number of sells
-
-100
-
Price
-
$31.53
Significant Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q3 2016
247 filings reported holding EBS - Emergent BioSolutions Inc. - Common Stock as of Q3 2016.
Emergent BioSolutions Inc. - Common Stock (EBS) has 197 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,869,477 shares
of 54,486,781 outstanding shares and own 66% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (3,678,168 shares), BlackRock Fund Advisors (2,290,379 shares), DIMENSIONAL FUND ADVISORS LP (2,046,250 shares), ACADIAN ASSET MANAGEMENT LLC (1,604,001 shares), STATE STREET CORP (1,549,338 shares), GLENMEDE TRUST CO NA (1,302,487 shares), RENAISSANCE TECHNOLOGIES LLC (1,178,111 shares), ABERDEEN ASSET MANAGEMENT PLC/UK (996,034 shares), GOLDMAN SACHS GROUP INC (835,448 shares), and BlackRock Institutional Trust Company, N.A. (795,824 shares).
This table shows the top 197 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.